Table 6 Clinical characteristics of HBoV-positive patients with or without MP
Variable | With MP (n = 29) | Without MP (n = 59) | X2/Z | P |
|---|---|---|---|---|
Gender | 1.107 | 0.293 | ||
Male | 21 (72.4%) | 36 (61.0%) | ||
Female | 8 (27.6%) | 23 (39.0%) | ||
Age | 3.313 | 0.191 | ||
< 2 | 17 (58.6%) | 39 (66.1%) | ||
2–5 | 8 (27.6%) | 18 (30.5%) | ||
≧ 5 | 4 (13.8%) | 2 (3.4%) | ||
Clinical features | ||||
Cough | 27 (93.1%) | 58 (98.3%) | 1.598 | 0.252 |
Wheezing | 5 (20.8%) | 20 (35.7%) | 1.732 | 0.292 |
Tachypnea | 4 (13.8%) | 11 (18.6%) | 0.324 | 0.765 |
Rales | 14 (48.3%) | 16 (28.6%) | 3.248 | 0.071 |
Fever | 18 (72.0%) | 35 (60.3%) | 1.028 | 0.455 |
WBC, 109/L | 7.6 (6.6, 10.5) | 10.0 (7.4, 12.0) | − 1.633 | 0.102 |
CRP, mg/L | 3.8 (1.8, 16.5) | 3.9 (0.94, 11.2) | − 0.284 | 0.776 |
LDH, U/L | 302.0 (270.0, 338.0) | 311.0 (273.0, 345.0) | − 0.705 | 0.480 |
AST, U/L | 31.3 (26.5, 35.3) | 36.1 (30.0, 40.8) | − 2.857 | 0.004* |
ALT, U/L | 12.8 (8.7, 16.7) | 15.6 (10.4, 21.2) | − 1.786 | 0.074 |
Hospitalization days | 7.0 (5.0, 8.8) | 6.0 (5.0, 8.0) | − 0.171 | 0.864 |
Severe pneumonia | 2 (6.9%) | 8 (13.8%) | 0.857 | 0.487 |